OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review
G. Gerganov, Tsvetoslav Georgiev, Maria Dimova, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2651-2676
Closed Access | Times Cited: 10

Showing 10 citing articles:

Genetic or therapeutic disruption of the Reelin/Apoer2 signaling pathway improves inflammatory arthritis outcomes
Laurent Calvier, Catherine R. Wasser, E. Blair Solow, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access

Adhesion molecules and atherosclerosis in ankylosing spondylitis: implications for cardiovascular risk
Miroslav Markov, Tsvetoslav Georgiev, Alexander Krasimirov Angelov, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1837-1848
Closed Access | Times Cited: 3

The genesis of cardiovascular risk in inflammatory arthritis: insights into glycocalyx shedding, endothelial dysfunction, and atherosclerosis initiation
Alexander Krasimirov Angelov, Miroslav Markov, Mariana Ivanova, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 10, pp. 2541-2555
Closed Access | Times Cited: 7

Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis
Panagiota Anyfanti, Elena Angeloudi, Athanasia Dara, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 834-834
Open Access | Times Cited: 2

Geographical Differences in the Safety and Efficacy of Tofacitinib Versus TNFi: A Post Hoc Analysis of ORAL Surveillance
Bogdan Batko, Sławomir Jeka, Piotr Wiland, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 5, pp. 1217-1235
Open Access | Times Cited: 2

Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry
Mehmet Tuncay Duruöz, Şebnem Ataman, Hatice Bodur, et al.
Rheumatology International (2023) Vol. 44, Iss. 2, pp. 291-301
Closed Access | Times Cited: 6

Causal Relationship between Rheumatoid Arthritis and Atherosclerosis Risk: A Mendelian Randomized Study
Qi-Pei Liu, Hong-Cheng Du, Ping-Jin Xie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Methotrexate & rheumatoid arthritis associated atherosclerosis: A narrative review of multidisciplinary approach for risk modification by the international board of experts
Ashot Avagimyan, Federica Fogacci, Nana Pogosova, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 2, pp. 102230-102230
Closed Access | Times Cited: 2

Unlocking the Future: New Biologic Therapies for Rheumatoid Arthritis
Sarika J Patil, Vandana M Thorat, Akshada Amit Koparde, et al.
Cureus (2024)
Open Access

Page 1

Scroll to top